MycoMedica

MycoMedica

Private
Shelton, WashingtonHealthcare & Life Scienceshttps://www.mycomedica.com

Last Round

Series A

Jun 1, 2022

Total Funding Raised

$60M

Momentum Score

25 /100

Company Overview

MycoMedica Life Sciences is a biotechnology company focused on developing genome drugs that harness the healing potential of fungi to benefit both people and the planet.

Sector

Healthcare & Life Sciences

Verticals

D2C Brands, Biotechnology, Supply Chain, Fashion & Beauty, E-commerce

Business Model

B2C

Customer Profile

Hardware Sales, Services & Consulting

AI Layer

Non-AI

Keywords

medicinal mushroomsfunctional mushroomsdietary supplementstraditional Chinese medicinemushroom extractsadaptogensherbal supplementsnutraceuticalsraw material supplierwholesale supplementsnatural cosmeticsherbal tincturesD2C brandmushroom coffee

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

MycoMedica Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

MycoMedica Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
Series AJun 1, 2022

Key People

Founding team and executive leadership

Sanjay Dube

Chief Executive Officer, President And Chief Medical Officer Board Member

Executive Team

MycoMedica Investors

Notable investors and investment history

InvestorRounds
Obvious VenturesSeries A
KittyHawk VenturesSeries A
True VenturesSeries A

MycoMedica Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

MycoMedica Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about MycoMedica's valuation, stock price, and market status.

Firmographic Details

HeadquartersShelton, Washington
Employee Range22
Year Founded2021
Last FundingJun 1, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.